ChemicalBook >> CAS DataBase List >>9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester

9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester

CAS No.
2256087-35-9
Chemical Name:
9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester
Synonyms
CL4H6 (removed);9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester;9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester
CBNumber:
CB89747267
Molecular Formula:
C59H113NO5
Molecular Weight:
916.53
MDL Number:
MOL File:
2256087-35-9.mol
Last updated:2024-07-02 08:55:39

9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester Properties

Boiling point 854.2±65.0 °C(Predicted)
Density 0.915±0.06 g/cm3(Predicted)
solubility DMSO: soluble
form Viscous Liquid
pka 15.21±0.29(Predicted)

9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester Chemical Properties,Uses,Production

Description

CL4H6 is an ionizable cationic amino lipid (apparent pKa = 6.35) that has been used in the generation of lipid nanoparticles (LNPs).1 LNPs containing CL4H6 and encapsulating Factor VII-targeting siRNA decrease hepatic levels of Factor VII in mice. Intravenous administration of LNPs containing CL4H6 and encapsulating siRNA targeting CD45 accumulate in tumor-associated macrophages and encapsulating siRNAs targeting STAT3 and HIF-1α decrease tumor volume in OS-RC-2 renal cancer mouse xenograft models.2

References

1. Sato, Y., Hashiba, K., Sasaki, K., et al. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo J. Control. Release 295,140-152(2019).
2. Shobaki, N., Sato, Y., Suzuki, Y., et al. Manipulating the function of tumor-associated macrophages by siRNA-loaded lipid nanoparticles for cancer immunotherapy J. Control. Release 325,235-248(2020).

9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester Preparation Products And Raw materials

Raw materials

Preparation Products

9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester Suppliers

Global( 13)Suppliers
Supplier Tel Email Country ProdList Advantage
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152 Mandy@hangyubiotech.com China 10985 58
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9707 58
Shanghai Changyu Medical Technology Co. Ltd. +86-13301875428 sales@changyuhe.com China 298 58
Shochem(Shanghai)Co.,Ltd +86-021-51783479 +86-13816874662 info@shochem.com China 304 58
DC Chemicals 021-58447131 13564518121 sales@dcchemicals.com China 9412 58
Tianjin Yankai Scientific Co. Ltd. 18500985499 yankaisale@qq.com China 419 58
InvivoChem 13549236410 sales@invivochem.cn China 6755 58
Shanghai Easy CDMO Co.,Ltd 021-61734564 August@easycdmo.com China 10010 58
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. 025-66113011 18112977050 cb5@aikonchem.com China 10529 58
Shandong Mopai Biotechnology Co., Ltd 13070690626 13053322091 admin@mopaikeji.com China 11056 58
9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester CL4H6 (removed) 9-Octadecenoic acid (9Z)-, 1,1'-[7-[4-(dipropylamino)butyl]-7-hydroxy-1,13-tridecanediyl] ester 2256087-35-9 C59H113NO5